Free Trial

Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health logo
$122.44 +2.10 (+1.75%)
(As of 02:20 PM ET)

Cardinal Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
5
Buy
7

Based on 13 Wall Street analysts who have issued ratings for Cardinal Health in the last 12 months, the stock has a consensus rating of "Hold." Out of the 13 analysts, 1 has given a sell rating, 5 have given a hold rating, and 7 have given a buy rating for CAH.

Consensus Price Target

$123.00
0.46% Upside
According to the 13 analysts' twelve-month price targets for Cardinal Health, the average price target is $123.00. The highest price target for CAH is $139.00, while the lowest price target for CAH is $101.00. The average price target represents a forecasted upside of 0.46% from the current price of $122.44.
Get the Latest News and Ratings for CAH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cardinal Health and its competitors.

Sign Up

CAH Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
3 Buy rating(s)
Hold
5 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
6 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$123.00$120.18$118.45$96.83
Forecasted Upside0.46% Upside7.09% Upside8.32% Upside-8.54% Downside
Consensus Rating
Hold
Moderate Buy
Moderate Buy
Hold

CAH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CAH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cardinal Health Stock vs. The Competition

TypeCardinal HealthMedical CompaniesS&P 500
Consensus Rating Score
2.46
2.80
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside2.21% Upside26,931.57% Upside9.83% Upside
News Sentiment Rating
Positive News

See Recent CAH News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/4/2024Deutsche Bank Aktiengesellschaft
3 of 5 stars
 Boost TargetHold ➝ Hold$119.00 ➝ $124.00+9.48%
11/4/2024Morgan Stanley
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$119.00 ➝ $127.00+12.13%
11/4/2024UBS Group
4 of 5 stars
 Boost TargetBuy ➝ Buy$134.00 ➝ $139.00+21.30%
11/4/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$110.00 ➝ $120.00+1.99%
11/4/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$117.00 ➝ $133.00+14.53%
9/11/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$115.00 ➝ $125.00+10.34%
8/21/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$111.00 ➝ $123.00+12.23%
8/15/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$95.00 ➝ $101.00-6.48%
8/15/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$130.00 ➝ $137.00+28.81%
8/15/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetIn-Line ➝ In-Line$105.00 ➝ $115.00+8.12%
7/19/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$115.00 ➝ $107.00+11.98%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$125.00+15.64%
8/16/2023TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$88.00 ➝ $90.00-0.56%
7/17/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$91.00 ➝ $99.00+6.29%
6/12/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$90.00 ➝ $100.00+15.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:46 PM ET.


Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, November 1, 2024. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

Cardinal Health
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

  • Cardinal Health, Inc. has a market capitalization of $26.98 billion, indicating a strong position in the market.
  • The company recently increased its quarterly dividend, showing commitment to rewarding shareholders.
  • Analysts have given Cardinal Health, Inc. a consensus rating of "Moderate Buy" with an average price target of $119.36, suggesting potential growth.
  • Cardinal Health, Inc. reported a positive EPS of $1.84 for the last quarter, beating the consensus estimate, indicating strong financial performance.
  • Despite trading down slightly, Cardinal Health, Inc. has a 1-year high of $116.05, showing potential for stock price appreciation.

Cardinal Health
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

  • Cardinal Health, Inc. has a high P/E ratio of 49.34, which may indicate an overvalued stock.
  • The company's negative return on equity of 54.85% raises concerns about profitability and efficiency.
  • While the dividend payout ratio is 89.78%, it may be unsustainable in the long term if earnings do not support it.
  • Cardinal Health, Inc. has a beta of 0.60, suggesting lower volatility compared to the market, which may limit potential returns.
  • With a price-to-earnings-growth ratio of 1.55, investors may find the stock less attractive for growth opportunities.

CAH Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Cardinal Health is $123.00, with a high forecast of $139.00 and a low forecast of $101.00.

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There is currently 1 sell rating, 5 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares.

According to analysts, Cardinal Health's stock has a predicted upside of 0.46% based on their 12-month stock forecasts.

Cardinal Health has been rated by research analysts at Argus, Barclays, Deutsche Bank Aktiengesellschaft, Mizuho, Morgan Stanley, and UBS Group in the past 90 days.

Analysts like Cardinal Health less than other "medical" companies. The consensus rating for Cardinal Health is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CAH compares to other companies.


This page (NYSE:CAH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners